LINC00052 inhibits tumor growth, invasion and metastasis by repressing STAT3 in cervical carcinoma

J. Lin, L.-L. Nong, M.-Q. Li, F.-C. Yang, S.-H. Wang, M.-J. Liu

Department of Pathology, Affiliated Hospital of Guilin Medical University, Guilin, China.

 

---

• Oncology

Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “LINC00052 inhibits tumor growth, invasion and metastasis by repressing STAT3 in cervical carcinoma, by J. Lin, L.-L. Nong, M.-Q. Li, F.-C. Yang, S.-H. Wang, M.-J. Liu, published in Eur Rev Med Pharmacol Sci 2019; 23 (11): 4673-4679–DOI: 10.26355/eurrev_201906_18047–PMID: 31210293” has been withdrawn.

The Publisher apologizes for any inconvenience this may cause.

https://www.staging.europeanreview.org/article/18047

Free PDF Download